State Drug Controller suspends manufacture of drug at Wockhardt plant

24-Apr-2014 - Indian authorities have suspended the manufacture of a Wockhardt fixed dose combination drug, the company has announced in a filing.

Opko acquires Israeli-made dry powder inhaler to treat respiratory disorders

24-Apr-2014 - Opko Health has agreed to acquire Inspiro Medical, an Israeli medical device company developing a new platform to deliver small molecule drugs such as corticosteroids and beta agonists or larger molecules to treat respiratory diseases. 

Frutarom on the EU herbal situation: “The only real channel now is the THMPD..."

Frutarom becomes a bigger botanicals player with THMPD range

23-Apr-2014 - Swiss-Israeli supplier Frutarom has beefed up its botanical extracts in response to changing European Union laws for herbal products and medicines.

Novartis scoops GSK’s oncology portfolio, trades away its vaccine division

23-Apr-2014 - Novartis has agreed to acquire GlaxoSmithKline’s oncology pipeline for as much as $16bn, while GSK will acquire Novartis’ vaccine business, excluding the flu vaccines, for as much as $7bn.

UK generics makers and MHRA pool manufacturing knowledge

23-Apr-2014 - The British Generic Manufacturers Association (BGMA) and the UK Medicines and Healthcare Products Regulatory Agency (MHRA) will launch a forum for the generics industry to discuss manufacturing and quality issues.

Merck & Co. contracts Catalent to make sublingual hayfever drugs

23-Apr-2014 - MSD has selected Catalent to manufacture two recently approved sublingual pollen extract drugs using its Zydis formulation platform.

What would you do with $100bn? Pfizer could be buying AstraZeneca

AZ for $100bn? Pfizer could buy Azerbaijan and keep the change

22-Apr-2014 - With Pfizer rumoured to be on the brink of a mega-merger with AstraZeneca, in-Pharmatechnologist.com brings you an interactive view of what £60bn ($101bn) could get.

Big Pharma pull out and share slump won’t silence RNAi advocates

22-Apr-2014 - RNA interference (RNAi) developers that saw stock prices fall after Novartis pulled out of the market last week have reiterated their belief in the therapeutic and revenue potential of gene silencing drugs. 

Hospira announces two US recalls due to manufacturing, supplier issues

22-Apr-2014 - Hospira has announced US recalls for seven lots of its propofol injection and one lot of 1% Lidocaine HCI Injection due to a glass contamination.

US to lose 140,000 jobs if status quo is maintained, PhRMA reports

18-Apr-2014 - Biopharma executives believe there will be strong growth in domestic R&D activities and biopharma manufacturing, but fewer workers will be needed as efficiencies in productivity are achieved across the industry, according to a new survey from industry group PhRMA. 

Albemarle to sell ibuprofen business to SI Group

17-Apr-2014 - Albemarle has agreed to sell its ibuprofen business to US chemical intermediates firm SI Group in a deal that will also see it divest the anaesthetic agent, propofol.

Swiss site for API maker Cerbios combines chemical and biological R&D

17-Apr-2014 - Swiss high potency active pharmaceutical ingredient (API) contractor Cerbios has broken ground on a building that will bring together its chemical and biological R&D departments.

Anti social? Big Pharma balks at US FDA social media guidance

17-Apr-2014 - Comments from Novartis, Eli Lilly and Pfizer revealed that industry is taking serious issue with some aspects of the draft guidance from the US FDA on social media and promotional materials online.

Amine goldmine: BASF commits to new plant citing growing demand

16-Apr-2014 - The amines market will grow 5% over the next decade according to BASF, which cited rising drugmaker demand as a key driver for its investment in a new German plant.

Discovery of tampered vials leads to Roche cancer drug recall

16-Apr-2014 - Roche has recalled nine batches of breast cancer drug Herceptin after tampered vials were discovered in the UK, Finland and Germany.

Thermo Fisher: new pumps compatible with all bioprocessing techs

16-Apr-2014 - Thermo Fisher has launched a pump technology designed for applications across the bioprocessing production line and usable with "all" bioprocessing tech.

Pfizer cold on Viagra-laced ice cream idea

15-Apr-2014 - Pfizer has reminded the creator of Viagra-flavoured ice cream that the blockbuster erectile dysfunction treatment should only be available on prescription.

Hovione gets US patent for simple, patient-inspired inhaler

15-Apr-2014 - Hovione has obtained a US patent for a cheap capsule-based dry powder inhaler that it claims is cheaper for manufacturers to produce and easier for patients to use.

Novartis eyes Asian market with $160m Singapore ophthalmic plant

15-Apr-2014 - Novartis subsidiary Alcon has opened the doors to its new $160m facility in Singapore for the manufacture of ophthalmic drugs.

Acura pays Pfizer $2m to buy back anti-abuse tech and relaunch Oxecta drug

15-Apr-2014 - Acura has reacquired the rights to its opioid abuse-deterrent technology from Pfizer and is looking for pharma partners to relaunch its oxycodone HCL drug Oxecta.